VRCA - Financial Reports List - Verrica Pharmaceuticals Inc. - IntrinsicAlpha

Verrica Pharmaceuticals Inc. VRCA

Healthcare - Biotechnology - NASDAQ - US

$ 0.4929

-5.12 %

$ 45.2 M

Market Cap

-0.31

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	-82.70%	34.18%	44.61%
Annual Report	FY	10-K	2024-12-31	47.66%	-14.31%	-0.24%
Quarterly Report	Q3	8-K	2024-09-30	-61.06%	7.83%	13.43%
Quarterly Report	Q2	8-K	2024-06-30	2744.51%	-56.38%	-30.91%
Quarterly Report	Q1	8-K	2024-03-31	10240.54%	-208.56%	-162.36%
Quarterly Report	Q4	8-K	2023-12-31	2823.53%	-335.57%	-231.55%
Annual Report	FY	10-K	2023-12-31	-43.27%	-142.05%	-208.79%
Quarterly Report	Q3	8-K	2023-09-30	-64.94%	-29881.93%	-1651.73%
Quarterly Report	Q2	8-K	2023-06-30	-14.95%	2.01%	-27.35%
Quarterly Report	Q1	8-K	2023-03-31	-91.42%	30.86%	4.33%

1